Methods for suppressing activity of activated interferon-producing cells
The present invention provides agents for regulating the activity of interferon-producing cells (IPCs), which comprise as active ingredients antibodies that bind to BST2 and/or to its homologues, and methods for regulating IPC activity that use these antibodies. According to the present invention, the ability of IPCs to produce interferons (IFNs) and the number of cells can be directly regulated. The present invention also provides uses of BST2 and/or its homologues as markers for IPC activation. Compounds that regulate IPC activation can be screened using the markers for IPC activation.
1. A method for suppressing an activity of an activated interferon-producing cell, which comprises the step of contacting the activated interferon-producing cell with an antibody that binds bone marrow stromal cell antigen 2 (BST2), thereby suppressing the activity of the activated interferon-producing cell.
2. The method of claim 1 for suppressing an activity of an activated interferon-producing cell, wherein the activity of the activated interferon-producing cell is either or both of the activity of producing interferon or survival of the activated interferon-producing cell.
3. The method of claim 1 , wherein the contact is achieved by administering the antibody to a subject in need thereof.
4. The method of claim 1 , wherein the antibody is an antibody against a protein comprising the amino acid sequence of any one or more of SEQ ID NO: 2, 4 or 6.
5. The method of claim 4 , wherein the antibody binds a region comprising the amino acid sequence of position 139 to 158 from the N terminus of the amino acid sequence of SEQ ID NO: 4.
6. The method of claim 4 , wherein the antibody binds a region comprising the amino acid sequence of position 96 to 100 from the N terminus of the amino acid sequence of SEQ ID NO: 6.
7. The method of claim 4 , wherein the antibody is a monoclonal antibody.
8. The method of claim 1 , wherein the antibody is produced by the hybridoma 3D3#7 deposited under FERM BP-10339 or the hybridoma 307#6 deposited under FERM BP-10340, or a fragment thereof comprising an antigen-binding domain.
9. The method of claim 1 , wherein the BST2 is a human or mouse BST2.
10. The method of claim 9 , wherein the BST2 is a human BST2.
11. The method of claim 1 , wherein the activated interferon-producing cell is a precursor cell of a dendritic cell.
12. The method of claim 1 , wherein the antibody is an antibody that binds BST2 and that binds to the activated interferon-producing cell, thereby allowing the antibody to effectively suppress the activity of the activated interferon-producing cell.
13. A method for suppressing an activity of an activated interferon-producing cell, comprising the steps of:
(1) identifying an activated interferon-producing cell; and
(2) contacting the activated interferon-producing cell with an antibody that binds bone marrow stromal cell antigen 2 (BST2), thereby suppressing the activity of the activated interferon-producing cell.
14. The method of claim 13 , wherein the identification comprises determining the level of bone marrow stromal cell antigen 2 (BST2).
15. The method of claim 13 , wherein the identification comprises determining the level of interferon produced by the interferon-producing cell.